AC Immune SA reports results for the quarter ended in June - Earnings Summary

AC Immune SA

04/08/2023 14:33

* AC Immune SA  ACIU.OQ  reported a quarterly adjusted loss
of 20
rappen​​ per share for the quarter ended in June. The mean
expectation of three analysts for the quarter was for a loss
of 20 rappen per share.
    * Reported revenue was zero​; analysts expected CHF1.67
million. 
    * AC Immune SA's reported EPS for the quarter was a loss
of 20
rappen​.
    * The mean earnings estimate of analysts had fallen by
about 0.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * AC Immune SA shares had fallen by 2.2% this quarter and
gained 41.7% so far this year.
    * The company reported a quarterly loss of CHF16.83 million.
    * Wall Street's median 12-month price target for AC Immune
SA is
$9.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 4 at 01:33 p.m. UTC. ​All figures in Swiss francs unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.20          -0.20          Met
 Mar. 31 2023      -0.23          -0.21          Beat
 Dec. 31 2022      -0.25          -0.23          Beat
 Sep. 30 2022      -0.24          -0.16          Beat